The authors conduct a foundational overview of the classification of cell and gene therapy in treating solid tumors and explore how it targets the crosstalk between cancer cells and the tumor immune microenvironment from cellular and molecular perspectives.
[Journal of Experimental & Clinical Cancer Research]